Voltammetric studies on mechanisms of dopamine efflux in the presence of substrates and cocaine from cells expressing human norepinephrine transporter

J Neurochem. 1998 Aug;71(2):653-65. doi: 10.1046/j.1471-4159.1998.71020653.x.

Abstract

The effects of substrates m-tyramine and beta-phenethylamine, as well as cocaine, on the DA efflux from a cell line stably expressing the human norepinephrine transporter (hNET) were investigated by using rotating disk electrode voltammetry. Both the substrates and cocaine induced apparent DA efflux in a concentration-dependent manner. Their EC50 values for inducing DA efflux were similar to their IC50 values for inhibiting DA uptake. The substrate-induced DA efflux was inhibited by various NET blockers, enhanced by raising the internal [Na+] with Na+,K+-ATPase inhibition, but was insensitive to membrane potential-altering agents valinomycin, veratridine, and high [K+]. The initial rate of m-tyramine-induced DA efflux was related to preloaded [DA] in a manner defined by a Michaelis-Menten expression. In contrast, DA efflux in the presence of cocaine displayed a much slower efflux rate, lower efficacy, was not stimulated by elevated internal [Na+], and was nonsaturable with preloaded [DA]. Single exponential kinetic analysis of the entire time course of the DA efflux showed that the apparent first-order rate constant for m-tyramine-induced DA efflux declined with increased preloaded [DA], whereas that for the DA efflux in the presence of cocaine was unchanged with varying preloaded [DA]. These results suggest that the substrates stimulate the NET-dependent DA efflux by increasing the accessibility of the NET to internal DA, whereas cocaine "uncovers" NET-independent DA efflux by reducing the accessibility of diffused/leaked external DA to the NET.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenergic Uptake Inhibitors / pharmacology
  • Animals
  • Binding, Competitive / physiology
  • Carrier Proteins / antagonists & inhibitors
  • Carrier Proteins / metabolism*
  • Cocaine / pharmacology*
  • Desipramine / pharmacology
  • Dopamine / analysis
  • Dopamine / metabolism*
  • Dopamine Uptake Inhibitors / pharmacology*
  • Dose-Response Relationship, Drug
  • Electrophysiology
  • Enzyme Inhibitors / pharmacology
  • Fluoxetine / analogs & derivatives
  • Fluoxetine / pharmacology
  • Humans
  • Ionophores / pharmacology
  • Kinetics
  • LLC-PK1 Cells / chemistry
  • LLC-PK1 Cells / drug effects
  • LLC-PK1 Cells / metabolism
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Norepinephrine / antagonists & inhibitors
  • Norepinephrine / metabolism
  • Norepinephrine Plasma Membrane Transport Proteins
  • Ouabain / pharmacology
  • Phenethylamines / pharmacology
  • Psychotropic Drugs / pharmacology
  • Swine
  • Symporters*
  • Time Factors
  • Tyramine / pharmacology
  • Valinomycin / pharmacology
  • Veratridine / pharmacology

Substances

  • Adrenergic Uptake Inhibitors
  • Carrier Proteins
  • Dopamine Uptake Inhibitors
  • Enzyme Inhibitors
  • Ionophores
  • Norepinephrine Plasma Membrane Transport Proteins
  • Phenethylamines
  • Psychotropic Drugs
  • SLC6A2 protein, human
  • Symporters
  • Fluoxetine
  • nisoxetine
  • Valinomycin
  • phenethylamine
  • Ouabain
  • Veratridine
  • Cocaine
  • 3-tyramine
  • Desipramine
  • Dopamine
  • Norepinephrine
  • Tyramine